Plain-English translation of NCT07179744 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Breast Cancer research guide →This study is following women with breast cancer who have a small number of affected lymph nodes but low risk of recurrence. Instead of giving radiation to the lymph nodes in the armpit and chest wall (a standard treatment), doctors want to see if these patients do just as well without that radiation. The study will track these patients over time to make sure they stay healthy.
Radiation therapy to lymph nodes can cause side effects like arm swelling, heart problems, and lung damage. If doctors can safely skip this treatment in certain low-risk patients, it would reduce harm while still keeping them safe from cancer coming back.
You likely qualify if…
You likely don't qualify if…
You would continue with your regular cancer follow-up appointments to monitor your health, but you would not receive radiation to your lymph nodes. Instead of standard regional radiotherapy, doctors will carefully track you with imaging, blood tests, and clinical visits to make sure the cancer does not return. This is an observational study, meaning researchers are watching and recording how you do over time rather than giving you a new medication.
AI-generated summary from trial data · Sep 17, 2026 · Not medical advice
China
Sponsor
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Collaborators
Sun Yat-sen University
Enrollment target
~635 participants
Started
July 2022
Primary completion
July 2027
Age range
18 Years – 70 Years
Sex
Female only
Last updated on clinicaltrials.gov in September 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Yuting Tan
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.